EW — Edwards Lifesciences Share News
0.000.00%
Last trade - 00:00- $54.44bn
- $50.89bn
- $6.07bn
Edwards Lifesciences CFO Scott Ullem to step down by mid-2026
Edwards Lifesciences beats Q3 sales estimates, raises full-year sales, adj EPS guidance
U.S. RESEARCH ROUNDUP-ATI, GoDaddy, Lyft
Health Rounds: Severe colon disorder on the rise in younger patients
Brief: Picard Announces Appointment Of Two New Members To Its Board Of Directors
Brief: Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase
Press Digest: Wall Street Journal - August 7
Brief: JenaValve Disagrees With FTC's Decision Against Proposed Edwards Lifesciences Deal
FTC seeks to block Edwards Lifesciences' acquisition of JenaValve (updated)
FTC seeks to block Edwards Lifesciences' acquisition of JenaValve
U.S. RESEARCH ROUNDUP- Carvana, CNX Resources, Estée Lauder
Edwards Lifesciences Corp reports results for the quarter ended June 30 - Earnings Summary
Edwards Lifesciences raises annual sales forecast on strong demand for heart devices
Brief: Edwards Lifesciences Q2 Adjusted EPS USD 0.67 Vs. IBES Estimate USD 0.62
Brief: FDA Says Edwards Lifesciences Is Recalling Arterial Cannula
Analysis: Five years after COVID, pharma shares languish in US policy limbo
Analysis: Five years after COVID, pharma shares languish in US policy limbo
Edwards Lifesciences Corp expected to post earnings of 62 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE- PepsiCo, Procter & Gamble